A double-blind crossover study compared sodium meclofenamate (300 mg daily) and ibuprofen (900 mg daily) in thirty patients with osteoarthritis. Each treatment period was of 3 weeks duration. Both drugs were effective in reducing the severity of joint symptoms and in improving the range of motion, with the exception of spine movement which did not show any changes from the baseline. Tolerance was good.
Get full access to this article
View all access options for this article.
References
1.
AccardoSCutoloMBianchiGCimminoM A (1981) Clinical trial of sodium meclofenamate for the treatment of rheumatoid arthritis. (English abstract). ReumatismoXXXIII, 1, 73.
2.
BennettG AWaineHBauerW (1942) Changes in the knee joint at various ages: with particular reference to the nature and development of degenerative joint disease. Commonwealth Fund. New York.
3.
CollierH O JSweetmanWJF (1968) Antagonism by fenamates of prostaglandin F2α and of slow reacting substance on human bronchial muscle. Nature219, 864.
4.
CutoloMRovidaSSamatàEAccardoS (1980) Effects of drugs on serum copper and its correlation with other humoral factors in rheumatoid arthritis. In: WilloughbyD A, Ed, Inflammation: mechanisms and treatment. MTP Press, Lancaster, p 453.
5.
DieppeP AHuskissonE CWilloughbyD A (1980) The inflammatory component of osteoarthritis. In: NukiG, Ed. The Aetiopathogenesis of Osteoarthrosis. Pitman M P Co. Ltd., Edinburgh, p 117.
6.
FlowerRGryglewskiRHerbaczynska-CedroKVaneJ R (1972) Effects of anti-inflammatory drugs on prostaglandins biosynthesis. Nature (New Biology)238, 104.
7.
GlazkoA JChangTBorondyP EWesleyA (1978) Metabolic disposition of meclofenamic acid (Meclomen) in laboratory animals and in man. Current Therapeutic Research23, 4, S22.
8.
KellgrenJ HLawrenceJ S (1957) Radiological assessment of osteoarthrosis. A nnals of the Rheumatic Diseases16, 494.
9.
LequesneM (1980) Directives europeennes pour les essais cliniques de nouveaux medicaments antirhumatismaux. Eular Bulletin9, 6, 182.
10.
MultzC VBrobynR DCaldwellJ R (1978) Sodium meclofenamate (Meclomen) vs aspirin for rheumatoid arthritis. Current Therapeutic Research23, 4, S72.
11.
PrestonS N (1978) Safety of sodium meclofenamate (Meclomen). Current Therapeutic Research23, 4, S107.
12.
RingroseP SParrM AMcLarenM (1975) Effect of anti-inflammatory and other compounds on the release of lysosomal enzymes from macrophages. Biochemical Pharmacology24, 607.
13.
SchleyerI (1978) European studies of sodium meclofenamate (Meclomen) in the treatment of osteoarthritis. Current Therapeutic Research23, 4, S121.
14.
SokoloffL (1980) The pathology of osteoarthrosis and the role of ageing. In: NukiG, Ed. The Aetiopathogenesis of Osteoarthrosis. Pitman M P Co. Ltd., Edinburgh p 1.
15.
WahlL MWahlS MMergerhagenS EMartinG R (1974) Collagenase production by endotoxin-activated macrophages. Proceedings of the National Academy of Sciences U.S.A.71, 3598.
16.
WaxJ (1978) Laboratory pharmacology of meclofenamic acid. Current Therapeutic Research23, 4, S3.
17.
WillkensR (1978) Experiences in the treatment of osteoarthritis of the hip and knee with sodium meclofenamate (Meclomen). Current Therapeutic Research23, 4, S81.
18.
WinderC V (1967) Experimental observations on flufenamic, mefenamic and meclofenamic acids. PharmacologyI.. In: Fenamates in Medicine. Annals of Physical Medicine Supplement p 7.
